Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart Johnson
Dale N Gerding

Showing results (191-200 of 283) with videos related to

Pageof 29
Sort By:
The New England Journal of Medicine|January 22, 2010
Treatment with monoclonal antibodies against Clostridium difficile toxinsIsrael Lowy, Deborah C Molrine, Brett A Leav, et al.
Infection Control and Hospital Epidemiology|November 8, 2014
Strategies to prevent Clostridium difficile infections in acute care hospitals: 2014 updateErik R Dubberke, Philip Carling, Ruth Carrico, et al.
Journal of Clinical Microbiology|July 24, 2015
Development and Validation of Digital Enzyme-Linked Immunosorbent Assays for Ultrasensitive Detection and Quantification of Clostridium difficile Toxins in StoolLinan Song, Mingwei Zhao, David C Duffy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 2013
Effect of nucleic acid amplification testing on population-based incidence rates of Clostridium difficile infectionCarolyn V Gould, Jonathan R Edwards, Jessica Cohen, et al.
The Lancet. Infectious Diseases|May 3, 2017
Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority studyRichard J Vickers, Glenn S Tillotson, Richard Nathan, et al.
Frontiers in Oral Health|January 5, 2024
The dual role for probiotics use in dental practicesDebra A Goff, Lynne V McFarland, Stuart Johnson, et al.
Infection Control and Hospital Epidemiology|October 10, 2024
Risk of rehospitalization due to <i>Clostridioides difficile</i> infection among hospitalized patients with <i>Clostridioides difficile</i>: a cohort studyEmily N Drwiega, Stuart Johnson, Larry H Danziger, et al.
Anaerobe|April 27, 2025
Clostridioides difficile is a bacterial priority pathogenWiep Klaas Smits, Kevin W Garey, Thomas V Riley, et al.
Plos Neglected Tropical Diseases|February 5, 2025
Enteritis necroticans and Clostridium perfringens type C; Epidemiological and pathological findings over the past 20 yearsStuart Johnson, Andrew M Skinner, Calob Lostutter, et al.
Microorganisms|April 28, 2023
<i>Lactobacillus</i> Bacteremia and Probiotics: A ReviewRavina Kullar, Ellie J C Goldstein, Stuart Johnson, et al.
Pageof 29

Showing results (191-200 of 283) with videos related to

Sort By:
Pageof 29
The New England Journal of Medicine|January 22, 2010
Treatment with monoclonal antibodies against Clostridium difficile toxinsIsrael Lowy, Deborah C Molrine, Brett A Leav, et al.
Infection Control and Hospital Epidemiology|November 8, 2014
Strategies to prevent Clostridium difficile infections in acute care hospitals: 2014 updateErik R Dubberke, Philip Carling, Ruth Carrico, et al.
Journal of Clinical Microbiology|July 24, 2015
Development and Validation of Digital Enzyme-Linked Immunosorbent Assays for Ultrasensitive Detection and Quantification of Clostridium difficile Toxins in StoolLinan Song, Mingwei Zhao, David C Duffy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 2013
Effect of nucleic acid amplification testing on population-based incidence rates of Clostridium difficile infectionCarolyn V Gould, Jonathan R Edwards, Jessica Cohen, et al.
The Lancet. Infectious Diseases|May 3, 2017
Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority studyRichard J Vickers, Glenn S Tillotson, Richard Nathan, et al.
Frontiers in Oral Health|January 5, 2024
The dual role for probiotics use in dental practicesDebra A Goff, Lynne V McFarland, Stuart Johnson, et al.
Infection Control and Hospital Epidemiology|October 10, 2024
Risk of rehospitalization due to <i>Clostridioides difficile</i> infection among hospitalized patients with <i>Clostridioides difficile</i>: a cohort studyEmily N Drwiega, Stuart Johnson, Larry H Danziger, et al.
Anaerobe|April 27, 2025
Clostridioides difficile is a bacterial priority pathogenWiep Klaas Smits, Kevin W Garey, Thomas V Riley, et al.
Plos Neglected Tropical Diseases|February 5, 2025
Enteritis necroticans and Clostridium perfringens type C; Epidemiological and pathological findings over the past 20 yearsStuart Johnson, Andrew M Skinner, Calob Lostutter, et al.
Microorganisms|April 28, 2023
<i>Lactobacillus</i> Bacteremia and Probiotics: A ReviewRavina Kullar, Ellie J C Goldstein, Stuart Johnson, et al.
Pageof 29